I höstas var Enginzyme med på Ny Tekniks 33-listan som ett av Sveriges bästa unga teknikbolag. Nu tar bolaget in 111 miljoner bland annat från Industrifonden.

Industrifonden | 3 293 följare på LinkedIn. Early stage venture capital fund based in Sweden. We focus on breakthrough technologies and science. | Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow.

Vi är baserade i Sverige men har en räckvidd över hela Norden. Vi letar efter genombrott som skapar morgondagens industrier. Våra kompetensområden är life science, högteknologi och innovativa affärsmodeller. Enginzyme tar nu in 11 miljoner euro från SEB Greentech och Industrifonden samt existerande ägare.

Industrifonden enginzyme

News . 2021-02-11 EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.

2021-02-11

Early-stage; 12 February 2021. Stiftelsen Industrifonden, doing business as Industrifonden, operates as a venture capital firm.

EnginZyme AB - Paving the way to cell free synthetic biology, the next Director of Enzyme Engineering at EnginZyme Deep Tech VC at Industrifonden.

The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste. Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders.

“EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry. The company is headquartered in Stockholm, Sweden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.
Våg 0 1 gram

Solna-bolaget Enginzyme står bakom en teknisk plattform för tillverkning av kemiska produkter, baserad på syntetisk biologi. Foto: Enginzyme Enginzyme: Nytt material gör industrin grönare Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.

“EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques The clever bit of what EnginZyme does is extracting the enzymes it wants from the E.coli bacteria to store in a stable form in a powdered material that’s easy to transport and use in any industrial process. This, Casimjee believes, will make it easier for industry to adopt enzymes more widely. Description EnginZyme's cell-free synthetic biology platform marries the efficiency of the chemical industry with the power and diversity of biology.
Victor lindberg ericsson

jonas bjelfvenstam transportstyrelsen
barnspecialistunderskoterska lon
max teleborg öppettider
hastighet lgf fordon
ic osterwa

The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.

To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme. Patrick Sobocki, Investment Manager. Read the company’s press release here. Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A. February 1, 2021 . Thesis . Synthetic Biology – enabling the nascent bioeconomy.